Lumina Psychiatry recognizes the challenges posed by Attention-Deficit/Hyperactivity Disorder (ADHD), a condition affecting both children and adults characterized by difficulty in maintaining attention, impulsivity, and hyperactivity. These symptoms can profoundly impact academic achievement, workplace performance, and interpersonal relationships. We are dedicated to providing personalized and comprehensive care tailored to the unique needs and goals of our patients. ADHD medication management

ADHD Medication Management NJ

Our team is committed to delivering specialized care for ADHD through a holistic approach that combines medication management and psychotherapy. This dual strategy aims to enhance concentration, reduce impulsivity, and improve overall functioning, ensuring the best outcomes for our patients.

ADHD Treatment Online in NJ

INCREASED PRODUCTIVITY WITH STIMULANT MEDICATION MANAGEMENT

Managing ADHD can be challenging, but with the right medication and support, individuals can significantly enhance their productivity and achieve their goals. Our tailored approaches include personalized therapy, medication management, and practical techniques designed to help you stay focused, organized, and productive. ADHD Psychiatrists in New Jersey

METHYLPHENIDATE-BASED STIMULANTS

Methylphenidate-based stimulants are among the most commonly prescribed medications for ADHD, known for their efficacy and safety. Our offerings include Ritalin, ideal for short-term symptom management with immediate relief lasting 3-4 hours. Concerta is designed for once-daily dosing, providing symptom control for 10-12 hours. Daytrana, a methylphenidate patch, offers a convenient transdermal option for consistent symptom management throughout the day.

AMPHETAMINE-BASED STIMULANTS

Amphetamine-based stimulants are another key option for ADHD treatment, offering distinct advantages for certain patients. Adderall, available in immediate-release and extended-release (Adderall XR) forms, enhances attention and focus while controlling impulsivity, with the immediate-release lasting 4-6 hours and the extended-release providing up to 12 hours of coverage. Vyvanse, a prodrug of dextroamphetamine, offers a gradual onset of effect and up to 14 hours of symptom control, with a reduced potential for abuse.